Condition: Posttraumatic Stress Disorder · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
The proposed study aims to evaluate the efficacy of intermittent theta-burst transcranial magnetic stimulation (iTBS) targeting primary motor cortex (M1) as adjunct treatment for PTSD patients. The primary outcome measure includes changes in PTSD symptom severity, with secondary outcome measures focusing on negative moods improvements, quality of life and social/occupation functioning and functional connectivity of the brain.
This description comes directly from the study's public registry record.
Huiqian Huang, Ph.D. · +8618757143725 · hhq0301@zju.edu.cn
Shanshan Li, Bachelor · 1252037349@qq.com
Always discuss trial participation with your own doctor first.
| Shanghai Mental Health Center | Shanghai, Shanghai Municipality, China | Recruiting |
| First Affiliated Hospital of Anhui Medical University | Hangzhou, Zhejiang, China | Recruiting |
| Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
| The Affiliated Kangning Hospital of Ningbo University | Ningbo, Zhejiang, China | Recruiting |
| Tongji Hospital of Tongji University | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06434766